This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Eberhard Karls Universitaet Tuebingen, Mayo Foundation for Medical Education and Research, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh. Active years: 2011-2013.
Company Filing History:
2 out of 12 
2 out of 1,805 
1 out of 15 
Years Active: 2011-2013
Title: Petra Herzig: Innovator in Neurodegenerative Disorder Research
Introduction
Petra Herzig is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of neurodegenerative disorders through her innovative research and discoveries. With a total of two patents to her name, her work focuses on the detection and treatment of conditions such as Parkinson's disease and Alzheimer's disease.
Latest Patents
Herzig's latest patents include the KASPP (LRRK2) gene, which is crucial for the detection and treatment of neurodegenerative disorders. This invention refers to a newly discovered gene named KASPP, or Kinase Associated with Parkinsonism with Pleiomorphic Pathology, alternatively known as LRRK2, or Leucine-Rich Repeat Kinase 2. The patent details the gene's production, biochemical characterization, and its application in diagnosing and treating various neurodegenerative disorders, including sporadic Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and other related conditions.
Career Highlights
Throughout her career, Petra Herzig has worked with esteemed institutions such as Eberhard Karls Universität Tübingen and the Mayo Foundation for Medical Education and Research. Her research has significantly advanced the understanding of neurodegenerative diseases and their underlying genetic factors.
Collaborations
Herzig has collaborated with notable colleagues, including Thomas Meitinger and Tim Matthias Strom, contributing to a rich exchange of ideas and research findings in her field.
Conclusion
Petra Herzig's innovative work in the realm of neurodegenerative disorders highlights her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving the lives of those affected by these challenging conditions.